Risks and Benefits of Soy Phytoestrogens in Cardiovascular Diseases, Cancer, Climacteric Symptoms and Osteoporosis

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.9, 2001-01, pp. : 665-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen Receptors as Targets for Drug Development for Breast Cancer, Osteoporosis and Cardiovascular Diseases

Current Cancer Drug Targets, Vol. 4, Iss. 6, 2004-09 ,pp. : 483-499

Bentham Science Publishers

Access to resources Recommend Favorite

The role of aspirin in cardiovascular diseases – forgotten benefits?

By Williams Adam Hennekens Charles H

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 109-115

Informa Healthcare

Access to resources Recommend Favorite

Risks and Benefits of Taxanes in Breast and Ovarian Cancer

By Michaud L.B.

Drug Safety, Vol. 23, Iss. 5, 2000-11 ,pp. : 401-428

Adis International

Access to resources Recommend Favorite

Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer

By Michaud L.B.

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 297-309

Adis International

Access to resources Recommend Favorite

Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks

Current Pharmaceutical Design, Vol. 13, Iss. 22, 2007-08 ,pp. : 2215-2227

Bentham Science Publishers

Access to resources Recommend Favorite